Does South Carolina Medicaid cover Wegovy and Zepbound in 2026?
No, not since Jan 1, 2026. As of Oct 23, 2026, South Carolina Medicaid no longer covers GLP-1 drugs for obesity alone.
Coverage ended in 2026 Checked Oct 23, 2026 Coverage ended Jan 1, 2026
Coverage of GLP-1 drugs for obesity alone under South Carolina’s fee-for-service Medicaid drug rules, as the state publishes them. The plan decides each request.
South Carolina’s rule
In plain words
Coverage ended in 2026
Coverage added Nov 1, 2024 and removed effective Jan 1, 2026.
Source
SCDHHS Pharmacy Services manual, change control record (opens in new tab). Checked Oct 23, 2026.
Federal Medicaid law lets a state exclude these drugs only “when used for anorexia, weight loss, or weight gain”; their use for type 2 diabetes is not on that list, though a state may require prior authorization. Social Security Act §1927(d)(1)(A) and (d)(2)(A), 42 U.S.C. 1396r-8(d) (opens in new tab).
What changed
- Jan 1, 2026: South Carolina Medicaid removed GLP-1 coverage for weight loss (added Nov 1, 2024). SCDHHS Pharmacy Services manual, change control record (opens in new tab)
Questions this page answers
Does South Carolina Medicaid cover Wegovy and Zepbound for weight loss?
No, not since Jan 1, 2026. As of Oct 23, 2026, South Carolina Medicaid no longer covers GLP-1 drugs for obesity alone. Coverage added Nov 1, 2024 and removed effective Jan 1, 2026.
Has South Carolina’s rule changed recently?
Jan 1, 2026: South Carolina Medicaid removed GLP-1 coverage for weight loss (added Nov 1, 2024).
Where does this information come from?
From SCDHHS Pharmacy Services manual, change control record, read on Oct 23, 2026. Federal Medicaid law lets a state exclude these drugs only “when used for anorexia, weight loss, or weight gain”; their use for type 2 diabetes is not on that list, though a state may require prior authorization.
Kymata Health reads each state’s own Medicaid documents. See every state on the map.